We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Advice on 510(k)s for Blood Glucose Monitoring Systems
FDA Issues Advice on 510(k)s for Blood Glucose Monitoring Systems
In two new guidances, the FDA calls for different types of information in 510(k) premarket submissions for blood glucose monitoring systems for use by healthcare professionals as compared to those for home use by lay-users.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor